am 251 has been researched along with Movement Disorders in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, MD | 1 |
| Boddington, LJ | 1 |
| Igelström, KM | 1 |
| Gray, JP | 1 |
| Shemmell, J | 1 |
| Tseng, KY | 1 |
| Oorschot, DE | 1 |
| Reynolds, JN | 1 |
1 other study available for am 251 and Movement Disorders
| Article | Year |
|---|---|
Utility of intracerebral theta burst electrical stimulation to attenuate interhemispheric inhibition and to promote motor recovery after cortical injury in an animal model.
Topics: Animals; Biophysics; Brain Injuries; Disease Models, Animal; Electroencephalography; Functional Late | 2014 |